Reduced intensity conditioning bone marrow transplantation for pure red cell aplasia: successful outcome but difficult post transplant course

被引:0
|
作者
G Kochethu
H S Baden
E Jaworska
J Chang
R Chopra
机构
[1] Adult Leukaemia Unit,
[2] Manchester Christie Hospital,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:81 / 82
页数:1
相关论文
共 50 条
  • [31] Pure red cell aplasia with isolated human herpes virus 6 infection of bone marrow in postcardiac transplant patient
    Todd, Kevin
    Paulsen, Grant
    Danziger-Isakov, Lara
    Tarango, Cristina
    PEDIATRIC BLOOD & CANCER, 2020, 67 (04)
  • [32] IMPORTANCE OF BONE MARROW CYTOLOGY IN THE EARLY DIAGNOSIS OF PURE APLASIA OF RED SERIES POST-TRANSPLANT ALLOGENIC OF HEMATOPOIETIC PROGENITORS
    Gasior Kabat, M.
    Humala Barbier, K.
    Morado Arias, M.
    De Paz Arias, R.
    Dos Santos Ortas, A.
    Garcia Perez, E.
    Panizo Echauri, I.
    Jimenez Yuste, V.
    Canales Albendea, M. A.
    HAEMATOLOGICA, 2018, 103 : 190 - 190
  • [33] Bone Marrow Transplantation with Reduced Intensity Conditioning for Diamond-Blackfan Anemia
    Nishimura, Akira
    Hirabayashi, Shinsuke
    Yamamoto, Shunsuke
    Aiga, Saori
    Nishitani, Misa
    Hosoya, Yosuke
    Mori, Shinichiro
    Hasegawa, Daisuke
    Manabe, Atsushi
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S92 - S93
  • [34] Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes
    Orly R. Klein
    Samantha Bapty
    Howard M. Lederman
    M. Elizabeth M. Younger
    Elias T. Zambidis
    Richard J. Jones
    Kenneth R. Cooke
    Heather J. Symons
    Journal of Clinical Immunology, 2021, 41 : 414 - 426
  • [35] Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes
    Klein, Orly R.
    Bapty, Samantha
    Lederman, Howard M.
    Younger, M. Elizabeth M.
    Zambidis, Elias T.
    Jones, Richard J.
    Cooke, Kenneth R.
    Symons, Heather J.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (02) : 414 - 426
  • [36] PURE RED-CELL APLASIA FOLLOWING ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION - RESPONSE TO ERYTHROPOIETIN
    PALTIEL, O
    COURNOYER, D
    RYBKA, W
    TRANSFUSION, 1993, 33 (05) : 418 - 421
  • [37] THE PROLIFERATIVE CAPACITY OF PURE RED-CELL APLASIA BONE-MARROW CELLS
    KATZ, LJ
    HOFFMAN, R
    RITCHEY, AK
    DAINIAK, N
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 1981, 54 (02): : 89 - 94
  • [38] No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation
    Wada, Sachie
    Asano-Mori, Yuki
    Yamamoto, Hisashi
    Yuasa, Mitsuhiro
    Kageyama, Kosei
    Kaji, Daisuke
    Nishida, Aya
    Ishiwata, Kazuya
    Takagi, Shinsuke
    Yamamoto, Go
    Uchida, Naoyuki
    Yoneyama, Akiko
    Makino, Shigeyoshi
    Taniguchi, Shuichi
    BONE MARROW TRANSPLANTATION, 2019, 54 (05) : 765 - 768
  • [39] No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation
    Sachie Wada
    Yuki Asano-Mori
    Hisashi Yamamoto
    Mitsuhiro Yuasa
    Kosei Kageyama
    Daisuke Kaji
    Aya Nishida
    Kazuya Ishiwata
    Shinsuke Takagi
    Go Yamamoto
    Naoyuki Uchida
    Akiko Yoneyama
    Shigeyoshi Makino
    Shuichi Taniguchi
    Bone Marrow Transplantation, 2019, 54 : 765 - 768
  • [40] Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant
    Sackett, Katie
    Cohn, Claudia S.
    Fahey-Ahrndt, Kayla
    Smith, Angela R.
    Johnson, Andrew D.
    JOURNAL OF CLINICAL APHERESIS, 2018, 33 (01) : 108 - 112